Newly released ASCO principles for responsible use of AI in oncology

Toni Choueiri shared a post by Julie Gralow, adding:

“Very important task force led by Debra Patt — a Must read!”

Quoting Julie Gralow‘s post:

“ASCO board member and chair of ASCO AI Task Force Debra Patt discusses newly released ASCO principles for responsible use of AI in oncology.”

Source: Toni Choueiri/X and Julie Gralow/X

Toni K. Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School. As a medical oncologist, clinical trialist, and translational researcher, he specializes in treating genitourinary cancers (prostate, bladder, testis, and kidney cancer), with a focus on kidney cancer.

Julie Gralow is the Chief Medical Officer (CMO) of the American Society of Clinical Oncology (ASCO). Previously, she was the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington School of Medicine, Professor in the Clinical Research Division of the Fred Hutchinson Cancer Research Center, as well as Director of Breast Medical Oncology at the Seattle Cancer Care Alliance. She is the founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN).